Oncology and X-Ray products company
Varian Medical Systems, Inc.
), and Siemens Healthcare, a part of
), recently revealed that technicians at The Ohio State
University are utilizing Varian software to conduct radiotherapy
sessions with linear accelerators manufactured by Siemens. The
two companies have created an interface that links the Aria
system from Varian with certain equipment of Siemens.
In Mar 2013, Siemens was granted 510(k) clearance from the
Food and Drug Administration for connectivity between Aria
software and two of its linear accelerators.
As per Varian, its software can function with 80% of Siemens
hardware. In fact, a large proportion of Siemens locations may
utilize Aria to handle different forms of care.
Siemens Healthcare is a leader in diagnostics, medical imaging
and other health care areas. The company offers a wide range of
offerings ranging from prevention to diagnosis.
Varian is a leading manufacturer of integrated radiotherapy
systems for cancer treatment and a premier supplier of X-Ray
tubes for diagnostic imaging applications. The company operates
in a technology-driven environment where success depends on the
use of new technology, product development and upgrades. In the
radiation oncology market, Varian competes with
The company is poised to increase its market share in
radiation oncology. It currently enjoys a healthy demand for its
coveted TrueBeam technology, which has meaningfully contributed
to its net order oncology growth. Varian's TrueBeam is designed
to treat tumors with beams of high speed and precision. It
incorporates several technological innovations such as patient
positioning and managing his/her motion. Given its high intensity
nature, TrueBeam can dispense strong dosage over twice as fast as
that possible with earlier equipment.
Moreover, Varian continues to post decent results despite the
contagion of economic problems in Europe and sustained softness
in certain end markets. It enjoys a strong balance sheet marked
by low debt and sizeable cash. The company also periodically
deploys capital to boost investor confidence via share
However, Varian competes with larger players in a
technology-intensive industry. Further, uncertainties stemming
from health care reform and a still weak hospital capital
spending environment across many developed countries, especially
in Europe, are significant challenges.
The stock carries a Zacks Rank #3 (Hold).
HeartWare International Inc.
) is Zacks Rank #2 (Buy) stock, which is expected to do well.
ACCURAY INC (ARAY): Free Stock Analysis
HEARTWARE INTL (HTWR): Free Stock Analysis
SIEMENS AG-ADR (SI): Free Stock Analysis
VARIAN MEDICAL (VAR): Free Stock Analysis
To read this article on Zacks.com click here.